PUBLISHER: BCC Research | PRODUCT CODE: 1348230
PUBLISHER: BCC Research | PRODUCT CODE: 1348230
The global market for hemoglobin A1c testing devices and kits is estimated to increase from $2.1 billion in 2023 to reach $3.2 billion by 2028, at a compound annual growth rate (CAGR) of 9.2% from 2023 through 2028.
The global market for chromatography segment of hemoglobin A1c testing devices and kits is estimated to increase from $940.6 million in 2023 to reach $1.4 billion by 2028, at a CAGR of 8.1% from 2023 through 2028.
The global market for assay techniques segment of hemoglobin A1c testing devices and kits is estimated to increase from $728.7 million in 2023 to reach $1.2 billion by 2028, at a CAGR of 9.8% from 2023 through 2028.
This report aims to provide a comprehensive study of the global market for Hemoglobin A1c Testing Devices & Kits. It describes the different types of Hemoglobin A1c Testing Devices & Kits products, technology, and their current and historical market revenues.
This report discusses the implications of the trends mentioned above in the context of the current size and growth of the diabetes market, in global terms and by the most important national markets. Companies in the relevant pharmaceutical and medical industries are discussed, with profiles of the leaders and an update on M&A activity. Five-year global sales forecasts are provided for the leading drug and device categories as well as breakdowns of the diabetes market by country.
Major players, competitive intelligence, innovative technologies, market dynamics and regional opportunities are discussed in detail. The report examines recent developments and product portfolios of major players. The report presents a market analysis and estimates the compound annual growth rate (CAGR) for the Market for Hemoglobin A1c Testing Devices and Kits.
This report segments the global market by these geographic regions: North America, Europe, Asia-Pacific and the Rest of the World. For market estimates, data is provided for 2022 as the base year, 2023, and forecast through year-end 2028.